JWA
AMPH icon

JFS Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

JFS Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122 Buy
+6
New +$121 ﹤0.01% 2212
2025
Q1 		– Sell
-3
Closed -$112 – 1939
2024
Q4 		$112 Hold
3
– – ﹤0.01% 1880
2024
Q3 		$146 Hold
3
– – ﹤0.01% 1885
2024
Q2 		$120 Sell
3
-8
-73% -$332 ﹤0.01% 1922
2024
Q1 		$484 Sell
11
-1
-8% -$52 ﹤0.01% 1790
2023
Q4 		$743 Buy
12
+8
+200% +$420 ﹤0.01% 1718
2023
Q3 		$184 Hold
4
– – ﹤0.01% 1870
2023
Q2 		$230 Buy
4
+2
+100% +$89 ﹤0.01% 1864
2023
Q1 		$75 Sell
2
-2
-50% -$66 ﹤0.01% 1908
2022
Q4 		$112 Buy
+4
New +$116 ﹤0.01% 1876

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JFS Wealth Advisors's AMPH Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 6 shares worth $122. The stake represents ﹤0.01% of the portfolio and ranks #2212 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in AMPH as recently as Q4 2024.

JFS Wealth Advisors first reported a position in AMPH in Q4 2022 and has held it in 10 quarters since. The position peaked at $743 in Q4 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • JFS Wealth Advisors held 6 shares of Amphastar Pharmaceuticals worth $122 as of Q2 2026.
  • Amphastar Pharmaceuticals was a new JFS Wealth Advisors position in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2212 holding.
  • JFS Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
  • JFS Wealth Advisors's Amphastar Pharmaceuticals position peaked at $743 in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.